Brief: Pharming Group Anticipates $7 Mln Restructuring Costs In Q4

Pharming

06/10/2025 16:58

Oct 6 (Reuters) - Pharming Group NV PHAR.AS:

ANTICIPATES $7 MILLION RESTRUCTURING COSTS IN Q4 2025

ANNOUNCES ORGANIZATIONAL RESTRUCTURING TO ACCELERATE GROWTH

TO REDUCE NON-COMMERCIAL AND NON-MEDICAL HEADCOUNT BY 20%

TO REDUCE G&A EXPENSES BY 15% OR $10 MILLION ANNUALLY

Source text: ID:nGNE1npjQT

Further company coverage: PHAR.AS

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com ; +48 58 769 66 00;;))